MONKEY POX ?A LOOMING HEALTH CRISIS FOR THE WORLD
DOI:
https://doi.org/10.69656/pjp.v18i2.1465Keywords:
Monkeypox, non-endemic spread, TecovirimatAbstract
Monkeypox is similar to Small Pox but it is less severe and less infectious than the small pox. Smallpox vaccination was approximately 85% protective against monkeypox. Ninety-two confirmed cases and twenty-eight suspected cases of Monkeyvirus were reported to World Health Organization between 13 to 21 May 2022 in 12 non-endemic countries in Europe, the United States, and the United Kingdom. Monkeypox is still a serious illness because of its complications, from the effects of sepsis and encephalitis to blindness from eye infections; nearly one in ten people infected are at risk of fatal complications, especially among young children. There is no diagnostic facility available in Pakistan. Health professionals should rely on their clinical skills to diagnose monkeypox. Flu-like symptoms are common initially, ranging from fever and headache to shortness of breath. One to 10 days later, a rash can appear on the extremities, head or torso that eventually turns into blisters filled with pus. Monkeypox produces smallpox-like skin lesions. Macules leading to Papules, Vesicles, Pustules, Scabs, Rash resolved in 14 to 21 days. An antiviral agent known as Tecovirimat is licensed by the European Medical Association (EMA) for monkeypox in 2022.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.